BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 24, 2017
View Archived Issues
FRMPD4 gene found to be associated with differential sex risk in multiple sclerosis
Read More
Financing to support ADC Therapeutics' pipeline of antibody-drug conjugates
Read More
Global Blood Therapeutics discontinues IPF program
Read More
Finch Therapeutics and Crestovo merge to form Finch Therapeutics Group
Read More
Favorable safety seen with AB-423 in healthy volunteers
Read More
Enanta Pharmaceuticals reports phase Ib/b trial results for lead FXR agonist
Read More
Agenus launches new subsidiary
Read More
Novel GLP-1-dexamethasone conjugates reverse immune-metabolic dysfunction and obesity
Read More
Mitochondria imaging with [18F]TAP-031 shows promise
Read More
Eisai and Biogen expand Alzheimer's collaboration agreement
Read More
FDA grants QIDP and fast track designations to Aemcolo for traveler's diarrhea
Read More
Cerveau signs license and supply agreement with AbbVie for use of [18F]MK-6240
Read More
Promising topline results from phase III ARROW study of once-weekly Kyprolis
Read More
FDA grants orphan drug status to RedHill Biopharma's Mesupron
Read More
FDA approves Soliris for AchR antibody-positive generalized myasthenia gravis
Read More
New gene therapy involving miR-132 shows promise for Huntington's disease
Read More
Topline results from phase III PEPITES study of Viaskin Peanut
Read More
GlaxoSmithKline patents hSTING modulators
Read More
Wilson Therapeutics to initiate pivotal phase III FOCuS study of WTX-101 in Wilson disease
Read More
GPR119 agonists presented by Mankind Pharma
Read More
Kitasato Institute and Sumitomo Dainippon sign antimicrobial resistance joint research agreement
Read More
